Latest Breaking News On - Congress on trends in medical mycology - Page 2 : comparemela.com

The Daily Briefing For October 11th: Stocks Lower | Rebel Yell Morning Market Report

The Daily Briefing For October 11th: Stocks Lower | Rebel Yell Morning Market Report
wallstreetrebel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreetrebel.com Daily Mail and Mail on Sunday newspapers.

United statesWhite houseDistrict of columbiaJanet yellenBill baxterCharles evansEnergy dayCompany meetingsAspen technologyWashington postUniversity of michigan consumer sentimentAmerican society of retina specialistsSenate majority leader mitch mcconnellBrent oil futuresErlanger research advance declineBiden administration

NovaBiotics drug progress in the spotlight at prestigious Aberdeen event

Deborah O'Neil, from NovaBiotics, will present data on the NR339 drug at a life sciences conference being held in Aberdeen

United kingdomChris foyDeborah oneilEuropean confederation of medical mycologyCongress on trends in medical mycologyDeboraho neilMedical mycologyEuropean confederationGranite cityDon based novabiotics

The Daily Briefing For October 8th: Weak Jobs Data, Stocks Mixed | Rebel Yell Morning Market Report

The Daily Briefing For October 8th: Weak Jobs Data, Stocks Mixed | Rebel Yell Morning Market Report
wallstreetrebel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreetrebel.com Daily Mail and Mail on Sunday newspapers.

United statesCiudad de la habanaJanet yellenJen psakiLevi straussBiden harris administrationErlanger research advance declineCompany meetingsSidoti co small cap conferenceOval officeCommunication servicesCourt auditoriumAmerican society of retina specialistsCongress on trends in medical mycologyBrent oil futuresDaily briefing for october

NovaBiotics to Present Preclinical Data on NP339 and Sponsor Symposium on New Antifungals at Upcoming 10th Congress on Trends in Medical Mycology

/PRNewswire/ NovaBiotics Ltd, a privately held clinical stage company developing novel immune based therapies for life-threatening and life-limiting.

United kingdomMartin hoeniglDanielw smithLance bermanOliver cornelyDeborah oneilNkechi azieNovabiotics ltdEuropean confederation of medical mycologyResearch associate at novabioticsScynexis incRx communications groupClinical developmentCongress on trends in medical mycologyDeboraho neilChief executive officer